Predictive oncology stock.
Assess the Predictive Oncology stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month POAI price targets.
Nov 27, 2023 · A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 7 brokerages have issued 1 year price targets for ALX Oncology's stock. Their ALXO share price targets range from $10.00 to $34.00. On average, they anticipate the company's stock price to reach $20.42 in the next year. This suggests a possible upside of 154.9% from the stock's current price. View analysts price targets for ALXO or view …Predictive Oncology Inc (NASDAQ:POAI) 3.22 Delayed Data As of 4:00pm ET +0.13 / +4.21% Today’s Change 2.47 Today ||| 52-Week Range 13.88 -47.49% Year-to-Date …Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued.
Predictive Oncology Inc (POAI) Message Board - Company Name: Predictive Oncology Inc, Stock Symbol: POAI, Industry: Medical - Healthcare - Total Posts: 4357 - Last Post: 07/15/2023 01:24:11 PM - company/specific stock board. Support: 888-992-3836 Home NewsWire SubscriptionsNov 30, 2023 · Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ... Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.
Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.
Traffic data maps play a crucial role in predictive analytics, providing valuable insights into the flow of traffic on roads and highways. Traffic data maps are visual representations that showcase real-time or historical traffic conditions...When is Predictive Oncology's earnings date? Predictive Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 19th, 2024 based off last year's report dates. Learn more on POAI's earnings history.The estimated Net Worth of J Melville Engle is at least $60 Thousand dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $56,950 and over the last 13 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today …२०२३ नोभेम्बर १४ ... ... Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of September 30, 2023 and December 31, 2022, 792, 792. Common ...
On Thursday 05/25/2023 the closing price of the Predictive Oncology Inc Registered Shs share was $3.07 on NAS. Compared to the opening price on Thursday 05/25/2023 on NAS of $3.01, this is a gain ...
Dec 22, 2021 · The upgrade of Predictive Oncology Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...
Dec 1, 2023 · Predictive Oncology Inc. (NASDAQ:POAI) issued its quarterly earnings results on Wednesday, August, 11th. The medical instruments supplier reported ($1.00) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.60) by $0.60. The medical instruments supplier had revenue of $0.35 million for the quarter, compared to the ... Predictive Oncology Inc. Common Stock (POAI) Stock Price, Quote, News & History | Nasdaq MY QUOTES: POAI Edit my quotes Predictive Oncology Inc. Common Stock (POAI) 0 Add to...Based on 79,403,893 shares of common stock issued and outstanding as of March 17, 2023, immediately following the Reverse Stock Split, the Company would have approximately 39,701,947 shares of common stock issued and outstanding (without giving effect to rounding for fractional shares) if the ratio for the Reverse Stock Split is one-for- …Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …Feb 21, 2023 · Predictive Oncology’s revenue increased by 45% to $455,000 in the most recent quarter, but the company continues to produce substantial losses. Thus, this is a relatively high-risk, high-upside ...
On April 21, 2023, Predictive Oncology Inc (POAI) experienced a 15.81% drop in share prices, trading at $0.23. This declinePredictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate.Find the latest Ikena Oncology, Inc. (IKNA) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 30, 2023 · Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ... Overview Press Releases Events & Presentations Financials & Filings Stock Quote & Chart Corporate Governance Contact Us Stock Quote (POAI) NASDAQ CM: POAI $3.17 Oct 2, 2023 4:00 PM EDT Change 0 (0.00%) Volume 0 Today's Open -- Previous Close $3.17 Today's High $3.20 Today's Low $3.07 52 Week High $13.88 52 Week Low $2.47 Stock ChartWall Street Stock Market & Finance report, prediction for the future: You'll find the Predictive Oncology share forecasts, stock quote and buy / sell signals below. According to present data Predictive Oncology's POAI shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Stay informed on POAI stock price history, news, and more at Stocks Telegraph. Get the latest updates on Predictive Oncology for smart investing.
Third, all of these shares are below a certain price of $ 3. As a result, they are relatively inexpensive, although the definition of penny stocks has changed over time. It basically includes all stocks traded for less than $ 5, although there are no hard and fast rules to talk about. They are here: ObsEva (NASDAQ: OBSV) Predictive oncology ...
See the latest Predictive Oncology Inc stock price (POAI:XNAS), related news, valuation, dividends and more to help you make your investing decisions.Discover historical prices for POAI stock on Yahoo Finance. View daily, weekly or monthly format back to when Predictive Oncology Inc. stock was issued.The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …FOSTER CITY, Calif., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that Thomas Bock, M.D., CEO of Notable Labs, will participate in a fireside chat at the JMP …Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.According to About.com, the fate of the children born on Wednesday in the poem “Monday’s Child” is that the child is full of woe. This poem was first written in 1838, but it is not believed that people ever really put much stock into its pr...Fiscal Q3 2023 ended 9/30/23. Reported on 11/14/23. Get the latest Predictive Oncology Inc (POAI) real-time quote, historical performance, charts, and other financial information …Predictive Oncology Stock Forecast and Price Target. The average price target for Predictive Oncology's stock lately set by several renowned analysts is $3.29, which would result in a potential upside of approximately 6.47% if it reaches this mark by December 31, 2023. This estimation is based on a high estimate of $3.69 and a low estimate of ...
Predictive Oncology appoints Bernard A. Harris, Jr., MD, MBA, venture capitalist and former NASA astronaut to serve on the company’s Business… Liked by Bob Myers Some of you know it as ...
Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ...
Predictive Oncology Inc (POAI) Stock Price & News - Google Finance Home POAI • NASDAQ Predictive Oncology Inc Follow Share $2.98 Nov 24, 5:45:00 PM GMT-5 · USD · NASDAQ · Disclaimer search... Here are three top AI stocks trading under $10 a share. Lantern Pharma Inc. ( LTRN ): A small, potential game-changer in the fight against cancer. Predictive Oncology (POAI): While risky, POAI ...The estimated Net Worth of Carl I. Schwartz is at least 4.75 百万$ dollars as of 22 October 2020. Dr Schwartz owns over 640 units of Predictive Oncology stock worth over 4,318,394$ and over the last 7 years he sold POAI stock worth over 544$. In addition, he makes 433,000$ as CEO & Director at Predictive Oncology.Predictive Oncology Inc. 2.9722. +0.0322. +1.10%. Company to host investor call and webcast today, August 10th, at 5:30pm EDTPITTSBURGH, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology ...Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023 GlobeNewswire 11d 3 AI Stocks Worth Buying Now for Multibagger ...The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes. 17 days ago • Morningstar View moreAug 10, 2023 · Predictive Oncology recorded revenue of $490,110 in the second quarter of 2023, compared to $371,591 in 2022. Sales of Streamway related products and services by our Eagan operating segment were ... The first of these is Predictive Oncology (NASDAQ: POAI). The company uses a proprietary AI platform to identify drugs that are likely to work against specific tumors. To facilitate this, the ...Predictive Oncology Inc (POAI) stock is higher by 5.43% while the S&P 500 has fallen -0.81% as of 1:18 PM on Monday, Jan 30. POAI has risen $0.02 from the previous closing price of $0.46 on volume of 290,855 shares. Over the past year the S&P 500 has fallen -10.58% while POAI has fallen -45.45%.The shares of Series F Preferred Stock will be distributed to such recipients a. EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology ...
Predictive Oncology Inc. PITTSBURGH, July 18, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and ...Predictive Oncology's common stock will continue to be traded on the Nasdaq Capital Market under the symbol POAI and will begin trading on a split-adjusted ...Predictive Oncology recorded revenue of $715,056 in the third quarter of 2023, compared to $455,827 for the comparable period in 2022. The increase in revenues related primarily to higher sales of ...Clovis Oncology (NASDAQ:CLVS) issued its quarterly earnings data on Wednesday, November, 3rd. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.48) by $0.08. The biopharmaceutical company had revenue of $37.92 million for the quarter, compared to …Instagram:https://instagram. cannabix stockhaxcbest whole life insurance cash valuebest discount dental plans Predictive Oncology (POAI) is a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development, such as …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you. wallstreetbets stocks listtemporary health insurance florida POAI U.S.: Nasdaq Predictive Oncology Inc. Watch list NEW Set a price target alert Premarket Last Updated: Oct 27, 2023 7:12 a.m. EDT Delayed quote $ 2.8800 0.02 0.70% Before Hours Volume: 35...Here are three artificial intelligence stocks that could be acquired. SoundHound ( AI ): The company is exposed to a $500 million a year opportunity with autos and restaurants. Predictive Oncology ... otc stock broker Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass" and the word λόγος (logos), meaning "study".Cancer survival has ...Feb 24, 2021 · Predictive Oncology includes various subsidiaries in the drug development and formulation space, as well as a legacy medical device business generating revenues, but this article focuses on their ... Feb 21, 2023 · Predictive Oncology’s revenue increased by 45% to $455,000 in the most recent quarter, but the company continues to produce substantial losses. Thus, this is a relatively high-risk, high-upside ...